Biological indices in the assessment of breast cancer
Open Access
- 1 October 1995
- journal article
- leaders
- Published by BMJ in Molecular Pathology
- Vol. 48 (5) , M221-M238
- https://doi.org/10.1136/mp.48.5.m221
Abstract
No abstract availableThis publication has 226 references indexed in Scilit:
- c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma—an immunocytochemical studyEuropean Journal Of Cancer, 1994
- Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivityEuropean Journal Of Cancer, 1993
- Cathepsin D levels in primary breast cancers: Relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal statusEuropean Journal Of Cancer, 1993
- Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: Correlation with steroid receptorsEuropean Journal Of Cancer, 1992
- Is DNA flow cytometry a useful investigation in breast cancer?European Journal Of Cancer, 1992
- Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?European Journal Of Cancer, 1992
- Expression of c-erbB-2 in in situ and in Adjacent Invasive Ductal Adenocarcinomas of the FemalePathobiology, 1992
- The p53 tumour suppressor geneNature, 1991
- Estrogen and oncogene mediated growth regulation of human breast cancer cellsJournal of Steroid Biochemistry, 1987
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985